This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analytical Instruments to Aid Thermo Fisher (TMO) Q2 Earnings?
by Zacks Equity Research
Solid global demand, substantial impact from the electron microscopy business and robust volume growth and productivity are likely to favor Thermo Fisher's (TMO) analytical instruments revenues.
What's in the Offing for Cerner's (CERN) Earnings in Q2?
by Zacks Equity Research
Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner's (CERN) Q2 earnings. However, expected decline in bookings is likely to be a dampener.
What's in Store for Varian Medical (VAR) in Q3 Earnings?
by Zacks Equity Research
Probable revenue growth in APAC and EMEA regions and higher Oncology revenues are likely to aid Varian Medical (VAR) in Q3 earnings. However, contraction in margins might be a dampener.
What's in Store for Align Technology (ALGN) in Q2 Earnings?
by Zacks Equity Research
Align Technology (ALGN) is expected to deliver a strong second quarter on continued adoption of Invisalign system.
Is a Beat in the Cards for Centene's (CNC) Q2 Earnings?
by Zacks Equity Research
Centene's (CNC) Q2 earnings are likely to be cushioned by higher revenues and membership.
BioTelemetry (BEAT) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
BioTelemetry's (BEAT) strong second-quarter 2019 expectations are indicative of solid results.
What's in Store for Edwards Lifesciences' (EW) Q2 Earnings?
by Zacks Equity Research
Edwards Lifesciences (EW) is likely to deliver a solid second quarter on robust segmental performance.
Can Global Industrial Unit Drive Ecolab's (ECL) Q2 Earnings?
by Zacks Equity Research
Ecolab (ECL) likely to see impressive growth in second-quarter adjusted earnings per share.
McKesson (MCK) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.
HCA Healthcare Buys Urgent Care Centers to Boost Portfolio
by Zacks Equity Research
HCA Healthcare (HCA) acquires urgent care centers in Austin, Dallas and Houston to enhance its portfolio.
Acadia Healthcare (ACHC) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Acadia Healthcare Up 32% YTD: What's Driving the Rally?
by Zacks Equity Research
Acadia Healthcare's strong presence in the growing behavioral healthcare business with solid fundamentals has helped the stock to rally.
Acadia Healthcare (ACHC) Down 1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hospital Industry Outlook: Demography, Consolidation Act As Tailwinds
by Sapna Bagaria
Hospital industry to gain from demographical changes and growing consolidation, partially offset by high labor cost.
Earnings Preview: Acadia Healthcare (ACHC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Acadia Healthcare (ACHC) Up 11.5% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Pick Acadia Healthcare (ACHC) Stock?
by Zacks Equity Research
Let's see if Acadia Healthcare (ACHC) stock is a good choice for value-oriented investors right now from multiple angles.
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Are Investors Undervaluing Acadia Healthcare (ACHC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Earnings Preview: Acadia Healthcare (ACHC) Q4 Earnings Expected to Decline
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Lies Ahead for Centene (CNC) Stock in Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter earnings are likely to gain traction from growth in revenues and membership strength, partly offset by high operating costs.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 earnings surge on the back of operating performance and strong growth across all core businesses.
HCA Healthcare's (HCA) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings rise on the back of robust same facility admissions.
Implied Volatility Surging for Acadia Healthcare (ACHC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
New Strong Sell Stocks for December 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: